A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.